tiprankstipranks
Trending News
More News >
Medistim ASA (DE:MD1)
FRANKFURT:MD1

Medistim ASA (MD1) Price & Analysis

Compare
1 Followers

MD1 Stock Chart & Stats


---

Financials

Options Prices

Currently, No data available
---

Ownership Overview

4.59%95.39%
Insiders
4.59%
Mutual Funds
― Other Institutional Investors
95.39% Public Companies and
Individual Investors

MD1 FAQ

What was Medistim ASA’s price range in the past 12 months?
Medistim ASA lowest stock price was €11.10 and its highest was €17.55 in the past 12 months.
    What is Medistim ASA’s market cap?
    Medistim ASA’s market cap is €249.27M.
      When is Medistim ASA’s upcoming earnings report date?
      Medistim ASA’s upcoming earnings report date is May 09, 2025 which is in 3 days.
        How were Medistim ASA’s earnings last quarter?
        Medistim ASA released its earnings results on Feb 28, 2025. The company reported €0.099 earnings per share for the quarter, missing the consensus estimate of €0.112 by -€0.013.
          Is Medistim ASA overvalued?
          According to Wall Street analysts Medistim ASA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Medistim ASA pay dividends?
            Medistim ASA pays a Annually dividend of €0.508 which represents an annual dividend yield of 2.86%. See more information on Medistim ASA dividends here
              What is Medistim ASA’s EPS estimate?
              Medistim ASA’s EPS estimate is 0.12.
                How many shares outstanding does Medistim ASA have?
                Medistim ASA has 18,337,336 shares outstanding.
                  What happened to Medistim ASA’s price movement after its last earnings report?
                  Medistim ASA reported an EPS of €0.099 in its last earnings report, missing expectations of €0.112. Following the earnings report the stock price went up 1.509%.
                    Which hedge fund is a major shareholder of Medistim ASA?
                    Currently, no hedge funds are holding shares in DE:MD1
                    ---

                    Company Description

                    Medistim ASA

                    Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Tempest Minerals Limited
                    Popular Stocks
                    ---
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis